Lunai Bioworks Statistics
NASDAQ: LNAIHealthcareBiotechnologyUSD
1.12+0.03 (+2.75%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Lunai Bioworks by the numbers
Lunai Bioworks has a market capitalization of $5.1 million based on 4.53M shares outstanding. With trailing EPS of $-63.61, Lunai Bioworks is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 47.0% below its 50-day average and 67.4% below its 200-day average.
Average daily trading volume is 181.21K shares, or about $202,951 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LNAI valuation vs. peer median
| Metric | LNAI | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.08M | $4.96M | +2% |
| Avg. volume | 181.21K | 288.64K | -37% |
Peer median across 8 companies: XBIO, LIMN, XTLB, DRMA, NCNA, CDIO, ENLV, PPCB.
Valuation
- Market cap
- $5.08M
- EPS (TTM)
- $-63.61
- Shares outstanding
- 4.53M
Price and trading
- Previous close
- 1.09
- Open
- 1.14
- Day range
- 1.10 – 1.15
- 52-week range
- 1.08 – 13.28
- Beta
- —
- Volume
- 14.85K
- Average volume
- 181.21K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 9, 2026
Additional statistics
- Market Cap
- 5.08M
- Eps
- -63.61
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 13.28
- Week52 Low
- 1.08
- Avg Volume
- 181.21K
- Shares Outstanding
- 4.53M
- Ma50
- 2.11
- Ma200
- 3.43
- Earnings Date
- Oct 9, 2026
- Pct From52w High
- -91.57%
- Pct From52w Low
- 3.70%